Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26355719
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Clin+Transl+Hepatol
2014 ; 2
(3
): 182-8
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Percutaneous Cryoablation for Liver Cancer
#MMPMID26355719
Niu LZ
; Li JL
; Xu KC
J Clin Transl Hepatol
2014[Sep]; 2
(3
): 182-8
PMID26355719
show ga
Based on the primary tumor site, liver cancer can be divided into two categories:
(1) primary liver cancer and (2) metastatic cancer to the liver from a distant
primary site. Guided cryoablation via many imaging methods induces iceball
formation and tumor necrosisand is an attractive option for treating unresectable
hepatocellular carcinoma (HCC) and metastatic liver cancer. There are several
advantages to using cryoablation for the treatment of liver cancer: it can be
performed percutaneously, intraoperatively, and laparoscopically; iceball
formation can be monitored; it has little impact on nearby large blood vessels;
and it induces a cryo-immunological response in situ. Clinically, primary
research has shown that percutaneous cryoablation of liver cancer is relatively
safe and efficient, and it can be combined with other methods, such as radiation
therapy, chemotherapy, and immunology, to control disease. Although research is
preliminary, cryosurgery is fast becoming an alternative treatment method for HCC
or liver tumors. Here, we review the mechanisms of liver tumor cryoablation,
cryoablation program selection, clinical efficiency, and complications following
treatment.
free
free
free
